{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:20:41Z","timestamp":1790709641960,"version":"4.1.0"},"reference-count":113,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T00:00:00Z","timestamp":1479168000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.vaccine.2016.11.015","type":"journal-article","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T12:18:09Z","timestamp":1479471489000},"page":"6681-6690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":193,"title":["Vaccination of special populations: Protecting the vulnerable"],"prefix":"10.1016","volume":"34","author":[{"given":"Mark","family":"Doherty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruprecht","family":"Schmidt-Ott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ignacio","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence R.","family":"Stanberry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika M.","family":"Hofstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony L.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.11.015_b0005","unstructured":"World Health Organization. Global Vaccine Action Plan 2011\u20132020, <http:\/\/www.who.int\/immunization\/global_vaccine_action_plan\/en\/> [accessed 20.04.16]."},{"key":"10.1016\/j.vaccine.2016.11.015_b0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/aji.12097","article-title":"Adaptive immune responses during pregnancy","volume":"69","author":"Zenclussen","year":"2013","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.vaccine.2016.11.015_b0015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/AOG.0000000000000581","article-title":"Vaccinations for pregnant women","volume":"125","author":"Swamy","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2016.11.015_b0020","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/AOG.0b013e3181d57947","article-title":"Severity of 2009 pandemic influenza A (H1N1) virus infection in pregnant women","volume":"115","author":"Creanga","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2016.11.015_b0025","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1056\/NEJMoa0908481","article-title":"Critical care services and 2009 H1N1 influenza in Australia and New Zealand","volume":"361","author":"Webb","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.11.015_b0030","unstructured":"World Health Organization. Summary of WHO position papers - recommendations for routine immunization. <http:\/\/www.who.int\/immunization\/policy\/Immunization_routine_Table1.pdf?ua=1> [accessed 20.04.16]."},{"key":"10.1016\/j.vaccine.2016.11.015_b0035","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1016\/j.vaccine.2015.08.035","article-title":"Maternal benefits of immunization during pregnancy","volume":"33","author":"Swamy","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.015_b0040","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMoa0708630","article-title":"Effectiveness of maternal influenza immunization in mothers and infants","volume":"359","author":"Zaman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.11.015_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2012.06.071","article-title":"A review of fetal and infant protection associated with antenatal influenza immunization","volume":"207","author":"Steinhoff","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2016.11.015_b0050","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1586\/14760584.2013.855612","article-title":"Introducing new vaccines in developing countries","volume":"12","author":"Kochhar","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.11.015_b0055","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0140-6736(14)60236-1","article-title":"Maternal and neonatal tetanus","volume":"385","author":"Thwaites","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.11.015_b0060","first-page":"CD002959","article-title":"Vaccines for women for preventing neonatal tetanus","volume":"7","author":"Demicheli","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2016.11.015_b0065","unstructured":"World Health Organization. Maternal and Neonatal Tetanus (MNT) elimination, http:\/\/www.who.int\/immunization\/diseases\/MNTE_initiative\/en\/ [accessed 20.04.16]."},{"key":"10.1016\/j.vaccine.2016.11.015_b0070","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/5584_2014_95","article-title":"Epidemiological and clinical reasons for vaccination against pertussis and influenza in pregnant women","volume":"849","author":"Nitsch-Osuch","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.vaccine.2016.11.015_b0075","first-page":"131","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women\u2013Advisory Committee on Immunization Practices (ACIP), 2012","volume":"62","author":"Advisory Committee on Immunization Practices","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.11.015_b0080","first-page":"433","article-title":"Pertussis vaccines: WHO position paper - September 2015","volume":"90","author":"World Health Organization","year":"2015","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2016.11.015_b0085","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1586\/14760584.2015.1043274","article-title":"Control of pertussis in infants: time has finally come?","volume":"14","author":"Safadi","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.11.015_b0090","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/S0140-6736(14)60686-3","article-title":"Effectiveness of maternal pertussis vaccination in England: an observational study","volume":"384","author":"Amirthalingam","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.11.015_b0095","doi-asserted-by":"crossref","first-page":"6420","DOI":"10.1016\/j.vaccine.2015.08.046","article-title":"Understanding factors influencing vaccination acceptance during pregnancy globally: a literature review","volume":"33","author":"Wilson","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.015_b0100","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMp1003462","article-title":"Enrolling pregnant women in research\u2013lessons from the H1N1 influenza pandemic","volume":"362","author":"Goldkind","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.11.015_b0105","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1001\/jama.2014.14825","article-title":"Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes","volume":"312","author":"Kharbanda","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2016.11.015_b0110","doi-asserted-by":"crossref","first-page":"g4219","DOI":"10.1136\/bmj.g4219","article-title":"Safety of pertussis vaccination in pregnant women in UK: observational study","volume":"349","author":"Donegan","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2016.11.015_b0115","first-page":"816","article-title":"Influenza vaccination coverage among pregnant women\u2013United States, 2013\u201314 influenza season","volume":"63","author":"Ding","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.11.015_b0120","doi-asserted-by":"crossref","first-page":"5445","DOI":"10.1016\/j.vaccine.2015.08.028","article-title":"Knowledge and attitudes of pregnant women and their providers towards recommendations for immunization during pregnancy","volume":"33","author":"Healy","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.015_b0125","unstructured":"Public Health England. Influenza immunisation programme for England. GP patient groups. Data collection survey. Season 2015 to 2016, <https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/544552\/Seasonal_flu_GP_patient_groups_annual_report_2015_2016.pdf> [accessed 05.10.16]."},{"key":"10.1016\/j.vaccine.2016.11.015_b0130","unstructured":"Public Health England. Pertussis vaccination programme for pregnant women update: vaccine coverage in England, January to March 2016, <https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/526208\/hpr1816_prntl-prtsss.pdf> [accessed 05.10.16]."},{"key":"10.1016\/j.vaccine.2016.11.015_b0135","unstructured":"World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2016 global summary. <http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/> [accessed 05.10.16]."},{"key":"10.1016\/j.vaccine.2016.11.015_b0140","article-title":"Evaluation of vaccine safety: practical aspects in assessing benefits and risks","volume":"XX","author":"Bonanni","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.015_b0145","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1586\/erv.12.93","article-title":"Immunogenicity, safety and tolerability of vaccinations in premature infants","volume":"11","author":"Esposito","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.11.015_b0150","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0022-3476(96)80131-4","article-title":"Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children","volume":"128","author":"Langkamp","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2016.11.015_b0155","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2006-2094","article-title":"Perinatal risk factors for hospitalization for pneumococcal disease in childhood: a population-based cohort study","volume":"119","author":"Mahon","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.11.015_b0160","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2013-305744","article-title":"Timely immunisation of premature infants against rotavirus in the neonatal intensive care unit","volume":"99","author":"Ladhani","year":"2014","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.vaccine.2016.11.015_b0165","unstructured":"Advisory Committee on Immunization Practices. Hepatitis B immunization management of preterm infants weighing <2,000 g, by maternal hepatitis B surface antigen (HBsAg) status, <http:\/\/www.cdc.gov\/hepatitis\/hbv\/pdfs\/correctedtable4.pdf> [accessed 20.04.16]."},{"key":"10.1016\/j.vaccine.2016.11.015_b0170","first-page":"129","article-title":"Pneumococcal vaccines WHO position paper\u20132012","volume":"87","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2016.11.015_b0175","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2010-1184","article-title":"Immunization of preterm infants with 10-valent pneumococcal conjugate vaccine","volume":"128","author":"Ome\u00f1aca","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.11.015_b0180","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1440-1754.2009.01573.x","article-title":"Immunisation practices in infants born prematurely: neonatologists\u2019 survey and clinical audit","volume":"45","author":"Crawford","year":"2009","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2016.11.015_b0185","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jpc.12481","article-title":"Improving preterm infants\u2019 immunisation status: a follow-up audit","volume":"50","author":"Crawford","year":"2014","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.vaccine.2016.11.015_b0190","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2013-3504","article-title":"Safety of rotavirus vaccine in the NICU","volume":"133","author":"Monk","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.11.015_b0195","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2013-0291","article-title":"Rotavirus vaccination of very low birth weight infants at discharge from the NICU","volume":"132","author":"Stumpf","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2016.11.015_b0200","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1016\/j.vaccine.2015.08.015","article-title":"Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units","volume":"33","author":"Thrall","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.015_b0205","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/jp.2011.111","article-title":"Underimmunization at discharge from the neonatal intensive care unit","volume":"32","author":"Navar-Boggan","year":"2012","journal-title":"J Perinatol"},{"key":"10.1016\/j.vaccine.2016.11.015_b0210","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.yapd.2012.04.017","article-title":"Immunization in special populations","volume":"59","author":"Miller","year":"2012","journal-title":"Adv Pediatr"},{"key":"10.1016\/j.vaccine.2016.11.015_b0215","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.11.015_b0220","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s11926-014-0431-x","article-title":"Vaccinations for rheumatoid arthritis","volume":"16","author":"Perry","year":"2014","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.vaccine.2016.11.015_b0225","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.3748\/wjg.v21.i11.3184","article-title":"Updates in vaccination: recommendations for adult inflammatory bowel disease patients","volume":"21","author":"Chaudrey","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2016.11.015_b0230","first-page":"1","article-title":"General recommendations on immunization \u2013- recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Advisory Committee on Immunization Practices","year":"2011","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2016.11.015_b0235","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S2213-8587(15)00379-4","article-title":"Diabetes and infection: assessing the association with glycaemic control in population-based studies","volume":"4","author":"Pearson-Stuttard","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.vaccine.2016.11.015_b0240","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jcf.2004.10.003","article-title":"Immunisation in the current management of cystic fibrosis patients","volume":"4","author":"Malfroot","year":"2005","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.vaccine.2016.11.015_b0245","first-page":"739","article-title":"Pneumococcal vaccination for cochlear implant candidates and recipients: updated recommendations of the Advisory Committee on Immunization Practices","volume":"52","author":"Advisory Committee on Immunization Practices","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.11.015_b0250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/1756285613501575","article-title":"Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner","volume":"7","author":"Oreja-Guevara","year":"2014","journal-title":"Ther Adv Neurol Disord"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2016.11.015_b0255","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ajt.12005","article-title":"Immune regulation of human herpesviruses and its implications for human transplantation","volume":"13","author":"Smith","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.vaccine.2016.11.015_b0260","doi-asserted-by":"crossref","first-page":"280rv2","DOI":"10.1126\/scitranslmed.aaa6853","article-title":"Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation","volume":"7","author":"McDonald-Hyman","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2016.11.015_b0265","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jcyt.2015.07.005","article-title":"Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"17","author":"Ma","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.vaccine.2016.11.015_b0270","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/bjh.13660","article-title":"A review of guidance on immunization in persons with defective or deficient splenic function","volume":"171","author":"Kuchar","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.vaccine.2016.11.015_b0275","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1046\/j.1198-743x.2001.00355.x","article-title":"Prevention and management of infections in patients without a spleen","volume":"7","author":"Davidson","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2016.11.015_b0280","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2337\/diacare.23.1.95","article-title":"Use of influenza and pneumococcal vaccines in people with diabetes","volume":"23","author":"Smith","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.vaccine.2016.11.015_b0285","first-page":"1","article-title":"Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices-United States, 2013\u20132014","volume":"62","author":"Advisory Committee on Immunization Practices","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2016.11.015_b0290","unstructured":"European Centre for Disease Prevention and Control. Guidance. Priority risk groups for influenza vaccination. <http:\/\/ecdc.europa.eu\/en\/publications\/Publications\/0808_GUI_Priority_Risk_Groups_for_Influenza_Vaccination.pdf> [accessed 20.04.16]."},{"key":"10.1016\/j.vaccine.2016.11.015_b0295","first-page":"1102","article-title":"Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23)","volume":"59","author":"Advisory Committee on Immunization Practices","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.11.015_b0300","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2893.2012.01616.x","article-title":"Prevalence of hepatitis B virus infection among persons with diagnosed diabetes mellitus in the United States, 1999\u20132010","volume":"19","author":"Schillie","year":"2012","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.vaccine.2016.11.015_b0305","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1177\/193229681200600417","article-title":"Increased risk of acute hepatitis B among adults with diagnosed diabetes mellitus","volume":"6","author":"Reilly","year":"2012","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.vaccine.2016.11.015_b0310","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/cid\/cit603","article-title":"Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study","volume":"57","author":"Huang","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.11.015_b0315","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s15010-014-0645-x","article-title":"Risk of herpes zoster among diabetics: a matched cohort study in a US insurance claim database before introduction of vaccination, 1997\u20132006","volume":"42","author":"Guignard","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.vaccine.2016.11.015_b0320","doi-asserted-by":"crossref","first-page":"ofu049","DOI":"10.1093\/ofid\/ofu049","article-title":"Incidence of herpes zoster and persistent post-zoster pain in adults with or without diabetes in the United States","volume":"1","author":"Suaya","year":"2014","journal-title":"Open Forum Infect Dis."},{"key":"10.1016\/j.vaccine.2016.11.015_b0325","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jinf.2013.06.016","article-title":"A population based study of the epidemiology of Herpes Zoster and its complications","volume":"67","author":"Weitzman","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2016.11.015_b0330","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/j.pain.0000000000000307","article-title":"A systematic review and meta-analysis of risk factors for postherpetic neuralgia","volume":"157","author":"Forbes","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.vaccine.2016.11.015_b0335","first-page":"1709","article-title":"Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Advisory Committee on Immunization Practices","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.11.015_b0340","doi-asserted-by":"crossref","first-page":"ofu024","DOI":"10.1093\/ofid\/ofu024","article-title":"Rates of pneumococcal disease in adults with chronic medical conditions","volume":"1","author":"Shea","year":"2014","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.vaccine.2016.11.015_b0345","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jcf.2015.04.006","article-title":"Vaccine coverage in CF children: a French multicenter study","volume":"14","author":"Masson","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.vaccine.2016.11.015_b0350","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2337\/diaclin.33.3.116","article-title":"Adherence to guidelines for hepatitis B, pneumococcal, and influenza vaccination in patients with diabetes","volume":"33","author":"Alcusky","year":"2015","journal-title":"Clin Diabetes"},{"key":"10.1016\/j.vaccine.2016.11.015_b0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.amepre.2015.04.013","article-title":"Interventions to improve adolescent vaccination: what may work and what still needs to be tested","volume":"49","author":"Dempsey","year":"2015","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.vaccine.2016.11.015_b0360","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.vaccine.2013.07.087","article-title":"Toward global prevention of sexually transmitted infections (STIs): the need for STI vaccines","volume":"32","author":"Gottlieb","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.015_b0365","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(07)60370-5","article-title":"Adolescents with a chronic condition: challenges living, challenges treating","volume":"369","author":"Sawyer","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2016.11.015_b0370","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1080\/21645515.2015.1067350","article-title":"Vaccination of adolescents with chronic medical conditions: special considerations and strategies for enhancing uptake","volume":"11","author":"Hofstetter","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.11.015_b0375","first-page":"93","article-title":"Advisory Committee on Immunization Practices recommended immunization schedules for persons aged 0 through 18 years\u2013United States, 2015","volume":"64","author":"Strikas","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.11.015_b0380","first-page":"1","article-title":"Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Broder","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2016.11.015_b0385","first-page":"1","article-title":"Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Cohn","year":"2013","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2016.11.015_b0390","first-page":"521","article-title":"Meningococcal vaccines: WHO position paper, November 2011","volume":"86","author":"World Health Organization","year":"2011","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2016.11.015_b0395","first-page":"521","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6\u201318 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"62","author":"Advisory Committee on Immunization Practices","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.11.015_b0400","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1158\/1940-6207.CAPR-13-0127","article-title":"Risk factors for non-initiation of the human papillomavirus vaccine among adolescent survivors of childhood cancer","volume":"6","author":"Klosky","year":"2013","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.vaccine.2016.11.015_b0405","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jpag.2012.05.004","article-title":"Human papillomavirus vaccination in female pediatric cancer survivors","volume":"25","author":"Hoffman","year":"2012","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.vaccine.2016.11.015_b0410","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1017\/S0950268807008436","article-title":"Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999\u20132005","volume":"136","author":"Pebody","year":"2008","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2016.11.015_b0415","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1016\/j.vaccine.2011.02.099","article-title":"Immunization coverage and timeliness of vaccination in Italian children with chronic diseases","volume":"30","author":"Pandolfi","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.015_b0420","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1001\/archpedi.153.1.27","article-title":"Preventive services received by adolescents with cystic fibrosis and sickle cell disease","volume":"153","author":"Britto","year":"1999","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.vaccine.2016.11.015_b0425","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1586\/14760584.2014.933076","article-title":"Factors impacting HPV vaccination: lessons for health care professionals","volume":"13","author":"Hofstetter","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2016.11.015_b0430","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.maturitas.2015.05.004","article-title":"Immunosenescence: Implications for response to infection and vaccination in older people","volume":"82","author":"Pera","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.vaccine.2016.11.015_b0435","first-page":"91","article-title":"Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older\u2013United States, 2015","volume":"64","author":"Kim","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.11.015_b0440","first-page":"461","article-title":"Vaccines against influenza WHO position paper - November 2012","volume":"87","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2016.11.015_b0445","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40121-014-0025-y","article-title":"Epidemiology of pneumococcal disease in a national cohort of older adults","volume":"3","author":"Morrill","year":"2014","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.vaccine.2016.11.015_b0450","first-page":"822","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among adults aged \u2a7e65 years: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"63","author":"Tomczyk","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.11.015_b0455","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.11.015_b0460","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/379048","article-title":"Decline in varicella-zoster virus (VZV)-specific cell-mediated immunity with increasing age and boosting with a high-dose VZV vaccine","volume":"188","author":"Levin","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.11.015_b0465","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1086\/651199","article-title":"Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses","volume":"201","author":"Weinberg","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.11.015_b0470","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.11.015_b0475","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciu918","article-title":"Long-term persistence of zoster vaccine efficacy","volume":"60","author":"Morrison","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.11.015_b0480","first-page":"1","article-title":"Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Harpaz","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2016.11.015_b0485","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.11.015_b0490","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2016.11.015_b0495","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1016\/j.vaccine.2015.08.082","article-title":"Seasonal influenza vaccine dose distribution in 195 countries (2004\u20132013): little progress in estimated global vaccination coverage","volume":"33","author":"Palache","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.015_b0500","unstructured":"Centers for Disease Control and Prevention. Flu vaccination coverage. United States, 2014-15 influenza season. <http:\/\/www.cdc.gov\/flu\/fluvaxview\/coverage-1415estimates.htm> [accessed 20.04.16]."},{"key":"10.1016\/j.vaccine.2016.11.015_b0505","first-page":"95","article-title":"Vaccination coverage among adults, excluding influenza vaccination - United States, 2013","volume":"64","author":"Williams","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.11.015_b0510","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ypmed.2014.10.017","article-title":"Factors affecting the uptake of vaccination by the elderly in Western society","volume":"69","author":"Eilers","year":"2014","journal-title":"Prev Med"},{"key":"10.1016\/j.vaccine.2016.11.015_b0515","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4161\/hv.35858","article-title":"Adult vaccination","volume":"11","author":"Swanson","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.11.015_b0520","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.coi.2013.05.014","article-title":"Vaccine strategies to enhance immune responses in the aged","volume":"25","author":"Lefebvre","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2016.11.015_b0525","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.4161\/hv.29254","article-title":"Vaccines for the elderly need to be introduced into the immunization program in India","volume":"10","author":"Verma","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2016.11.015_b0530","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1016\/j.vaccine.2013.08.056","article-title":"Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis","volume":"31","author":"Breteler","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.11.015_b0535","doi-asserted-by":"crossref","first-page":"51","DOI":"10.5365\/wpsar.2013.4.1.009","article-title":"Seasonal influenza vaccine policies, recommendations and use in the World Health Organization\u2019s Western Pacific Region","volume":"4","author":"Dwyer","year":"2013","journal-title":"Western Pac Surveill Response J"},{"key":"10.1016\/j.vaccine.2016.11.015_b0540","unstructured":"PAHO. PAHO\u2019s regional immunization vision and strategy 2007-2015, <http:\/\/www.who.int\/immunization\/sage\/PAHO_RIVS.pdf> [accessed 20.04.16]."},{"key":"10.1016\/j.vaccine.2016.11.015_b0545","first-page":"CD005188","article-title":"Interventions to increase influenza vaccination rates of those 60 years and older in the community","author":"Thomas","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2016.11.015_b0550","first-page":"CD003941","article-title":"Patient reminder and patient recall systems to improve immunization rates","author":"Jacobson Vann","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2016.11.015_b0555","first-page":"CD008145","article-title":"Interventions for improving coverage of childhood immunisation in low- and middle-income countries","volume":"7","author":"Oyo-Ita","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2016.11.015_b0560","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s12889-015-1470-6","article-title":"Effectiveness of short message services reminder on childhood immunization programme in Kadoma, Zimbabwe - a randomized controlled trial, 2013","volume":"15","author":"Bangure","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2016.11.015_b0565","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.2196\/resprot.5030","volume":"5","author":"Gibson","year":"2016","journal-title":"JMIR Res Protoc"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16310611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16310611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T17:01:53Z","timestamp":1537549313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16310611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":113,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0264410X16310611"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccination of special populations: Protecting the vulnerable","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}